Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism LOXL2 inhibitors(Lysyl oxidase homolog 2 inhibitors), LOXL3 inhibitors(lysyl oxidase like 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | AU | 09 Dec 2018 |